tiprankstipranks
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
US Market

Integra Lifesciences (IART) Ownership - Who Owns Integra Lifesciences?

Compare
240 Followers

Integra Lifesciences (IART) Ownership Overview

3.19%31.05%20.01%27.94%17.81%
20.01% Other Institutional Investors
27.94% ETFs
17.81% Public Companies and Individual Investors
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail, and individual investors. Approximately 79.00% of the company’s stock is owned by Institutional Investors, 3.19% is owned by Insiders, and 17.81% is owned by Public Companies and Individual Investors.
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail, and individual investors. Approximately 51.06% of the company’s stock is owned by Institutional Investors, 3.19% is owned by Insiders, and 27.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Dec 04, 2024
Eric Schwartz
Evp, Clo & Sec
xxxxxxxxxxxxx
$100081
Dec 03, 2024
Michael J. Mcbreen
Evp & President, Css
xxxxxxxxxxxxx
$41055
Aug 20, 2024
Jeffrey Mosebrook
Svp, Fin & Princ Acct Officer
xxxxxxxxxxxxx
$25690
May 24, 2024
Stuart Essig
Director
xxxxxxxxxxxxx
$1499742

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2024
xxxxxxxxxxxxx
$1070450
Dec 31, 2024
xxxxxxxxxxxxx
$2512263
Dec 31, 2024
xxxxxxxxxxxxx
$3016440

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,616,596Institution13.76%256,709,291
6,856,590Institution8.89%165,792,346
5,897,254Institution7.64%142,595,602
3,445,218Institution4.46%83,305,371
2,430,000Institution3.15%58,757,400
2,000,000Institution2.59%48,360,000
1,753,434Insider2.27%42,398,034
1,691,400Institution2.19%40,898,052
1,467,632Institution1.90%35,487,342
1,350,272Institution1.75%32,649,577

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,897,254Institution7.64%142,595,602
3,445,218Institution4.46%83,305,371
1,691,400Institution2.19%40,898,052
1,178,305Institution1.53%28,491,415
1,118,383Institution1.45%27,042,501
885,112Institution1.15%21,402,008
796,433Institution1.03%19,257,750
764,844Institution0.99%18,493,928
661,987Institution0.86%16,006,846
661,328Institution0.86%15,990,911

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
4,241,544Institution5.50%102,899,857
2,257,075Institution2.93%120,708,371
2,026,859Institution2.63%45,969,162
1,824,578Institution2.36%44,118,296
1,670,195Institution2.16%37,880,023
1,108,852Institution1.44%25,148,763
1,014,208Institution1.31%23,002,237
749,110Institution0.97%18,173,409
632,512Institution0.82%15,294,140
598,445Institution0.78%14,518,276

FAQ

Who Owns Integra Lifesciences Holdings Corp. (IART)?
According to the latest TipRanks data, approximately 20.01% of the company's stock is held by institutional investors, 3.19% is held by insiders, and 17.81% is held by retail investors.
    What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 20.01% of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors.
      What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors?
      According to the latest TipRanks data, approximately 17.81% of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors.
        Who owns the most shares of Integra Lifesciences Holdings Corp. (IART)?
        iShares owns the most shares of Integra Lifesciences Holdings Corp. (IART).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis